INCB161734
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for INCB161734, covering 2025-11-26 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]